title: Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data.
abstract: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can be used to quantify the response of tumors to vascular targeting agents. Tumor response is frequently assessed using mathematical models that describe the distribution of contrast agents over time as a function of fundamental characteristics of vascular physiology. Generally, mathematical models of biological systems are abstractions that attempt to retain fundamental physiologic characteristics, thereby allowing for multiple potential modeling approaches and structures. Various DCE-MRI modeling techniques are discussed in this article.
authors.affiliation: Early Development Pharmacokinetics & Pharmacodynamics, Genentech, South San Francisco, California, USA. ferl.gregory@gene.com
authors.forename: G Z
authors.initials: GZ
authors.lastname: Ferl
authors.forename: R E
authors.initials: RE
authors.lastname: Port
mesh_terms: D020533:Angiogenesis Inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use; D003287:Contrast Media; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D008279:Magnetic Resonance Imaging / Q000379:methods*; D055641:Mathematical Concepts; D008954:Models, Biological; D009369:Neoplasms / Q000098:blood supply / Q000175:diagnosis / Q000503:physiopathology; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000188:drug therapy; D010599:Pharmacokinetics; D000069437:Pharmacological Phenomena
chemical_list: D020533:Angiogenesis Inhibitors; D003287:Contrast Media